JMT Stock Analysis: Jeronimo Martins SGPS | LS
Food Distribution | LS, Portugal | Market Cap: 11.601m EUR | 12M Return: -14.8% | PTJMT0AE0001 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.2M
EPS Trend: -18.8%
Qual. Beats: 0
Rev. Trend: 98.7%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Jerónimo Martins SGPS, S.A. is a Portugal-headquartered food distribution group founded in 1792, operating across Portugal, Poland, Colombia, Slovakia, and other international markets. Its business is organized into five segments: Portugal Retail, Portugal Cash & Carry, Poland Retail, Poland Health and Beauty, and Colombia Retail. The company runs a multi-brand grocery and convenience store portfolio, including the Biedronka discount food chain in Poland, the Pingo Doce supermarket chain in Portugal, the Recheio cash-and-carry business, Hebe health and beauty stores, and the Ara proximity food chain in Colombia. It also operates online sales and delivery services, parapharmacies, petrol stations, coffee shops under the Jeronymo brand, and upstream activities such as dairy production, livestock farming, aquaculture, and crop farming. Ancillary operations include real estate transactions, sea passenger transport, air transport equipment rental, and retail management and logistics services. The company is a subsidiary of Sociedade Francisco Manuel Dos Santos B.V.
As a Consumer Staples / Food Retail operator, Jerónimo Martins relies on a high-volume, multi-format grocery model that combines discount stores, supermarkets, and cash-and-carry, which typically generates stable, recurring revenue tied to everyday essential purchases. Its geographic diversification across Iberia, Central Europe, and Latin America reduces dependence on any single national market and exposes the group to varying consumer price dynamics across regions.
- Biedronka Poland like-for-like sales drive consolidated revenue growth
- Ara Colombia store rollout accelerates but pressures group margins
- Polish wage inflation and PLN volatility squeeze Biedronka margins
| Net Income: 636.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.81 > 1.0 |
| NWC/Revenue: -8.84% < 20% (prev -9.90%; Δ 1.06% < -1%) |
| CFO/TA 0.14 > 3% & CFO 2.29b > Net Income 636.0m |
| Net Debt (3.01b) to EBITDA (2.45b): 1.23 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (628.4m) vs 12m ago 0.0% < -2% |
| Gross Margin: 20.84% > 18% (prev 20.54%; Δ 0.29% > 0.5%) |
| Asset Turnover: 229.0% > 50% (prev 225.9%; Δ 3.05% > 0%) |
| Interest Coverage Ratio: 3.33 > 6 (EBIT TTM 1.25b / Interest Expense TTM 376.0m) |
| A: -0.19 (Total Current Assets 5.14b - Total Current Liabilities 8.40b) / Total Assets 16.9b |
| B: 0.15 (Retained Earnings 2.58b / Total Assets 16.9b) |
| C: 0.08 (EBIT TTM 1.25b / Avg Total Assets 16.1b) |
| D: 0.23 (Book Value of Equity 3.13b / Total Liabilities 13.6b) |
| Altman-Z'' = -0.00 = B |
| DSRI: 1.17 (Receivables 100.0m/80.0m, Revenue 36.9b/34.6b) |
| GMI: 0.99 (GM 20.54% / 20.84%) |
| AQI: 0.95 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 1.07 (Revenue 36.9b / 34.6b) |
| TATA: -0.10 (NI 636.0m - CFO 2.29b) / TA 16.9b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of November 01, 2026, the stock is trading at EUR 18.46 with a total of 1,365,694 shares traded. Over the past week, the price has changed by +0.44%, over one month by +2.56%, over three months by +5.07% and over the past year by -14.78%.
Current recommended Stop Loss: 17.90 (which is 3% or 1.4 ATR below the current price).
Jeronimo Martins SGPS has no consensus analysts rating.
P/E Trailing = 18.2772
P/E Forward = 12.9702
P/S = 0.3112
P/B = 3.6699
P/EG = 1.4575
Revenue TTM = 36.9b EUR
EBIT TTM = 1.25b EUR
EBITDA TTM = 2.45b EUR
Long Term Debt = 627.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 798.0m EUR (from shortLongTermDebt, last quarter)
Debt = 4.60b EUR (Leases only: 4.60b)
Net Debt = 3.01b EUR (calculated: Debt 4.60b - CCE 1.58b)
Enterprise Value = 14.6b EUR (11.6b + Debt 4.60b - CCE 1.58b)
Interest Coverage Ratio = 3.33 (Ebit TTM 1.25b / Interest Expense TTM 376.0m)
EV/FCF = 12.26x (Enterprise Value 14.6b / FCF TTM 1.19b)
FCF Yield = 8.16% (FCF TTM 1.19b / Enterprise Value 14.6b)
FCF Margin = 3.23% (FCF TTM 1.19b / Revenue TTM 36.9b)
Net Margin = 1.72% (Net Income TTM 636.0m / Revenue TTM 36.9b)
Gross Margin = 20.84% ((Revenue TTM 36.9b - Cost of Revenue TTM 29.2b) / Revenue TTM)
Gross Margin QoQ = 20.70% (prev 21.05%)
Tobins Q-Ratio = 0.86 (Enterprise Value 14.6b / Total Assets 16.9b)
Interest Expense / Debt = 8.18% (Interest Expense 376.0m / Debt 4.60b)
Taxrate = 25.80% (226.0m / 876.0m)
NOPAT = 929.0m (EBIT 1.25b * (1 - 25.80%))
Current Ratio = 0.61 (Total Current Assets 5.14b / Total Current Liabilities 8.40b)
Debt / Equity = 1.47 (Debt 4.60b / totalStockholderEquity, last quarter 3.13b)
Debt / EBITDA = 1.23 (Net Debt 3.01b / EBITDA 2.45b)
Debt / FCF = 2.53 (Net Debt 3.01b / FCF TTM 1.19b)
Total Stockholder Equity = 3.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 636.0m / Total Assets 16.9b)
RoE = 19.68% (Net Income TTM 636.0m / Total Stockholder Equity 3.23b)
RoCE = 32.44% (EBIT 1.25b / Capital Employed (Equity 3.23b + L.T.Debt 627.0m))
RoIC = 13.41% (NOPAT 929.0m / Invested Capital 6.93b)
WACC = 5.43% (E(11.6b)/V(16.2b) * Re(5.18%) + D(4.60b)/V(16.2b) * Rd(8.18%) * (1-Tc(0.26)))
Discount Rate = 5.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈1.10b ; Y1≈1.26b ; Y5≈1.85b
[DCF] Fair Price = 39.52 (EV 27.8b - Net Debt 3.01b = Equity 24.8b / Shares 628.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -18.84 | EPS CAGR: -0.93% | SUE: -0.34 | # QB: 0
Revenue Correlation: 98.74 | Revenue CAGR: 7.98% | SUE: 0.03 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.24 | Chg30d=-3.59% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=1.15 | Chg30d=-3.58% | Revisions=-67% | GrowthEPS=-2.9% | GrowthRev=+4.5%
EPS next Year (2027-12-31): EPS=1.29 | Chg30d=-3.29% | Revisions=-62% | GrowthEPS=+11.7% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: -67% (up=1, down=11)